Sodium Valproate Drugs, Importers, Informations, User, warnings, Reviews, Side, Effects, CAS number 1069-66-5, Formula C8H15NaO2, Molecular Weight 166.19, Symptoms, Raw Material Exporters, Details, Drug Effectiveness, Sodium Valproate, fda, Information of Diseases, Drug, Details, Emergency, Interactions, api, Active Pharmaceutical Ingredients, Dosage, Taj Pharmaceuticals LTd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

active Pharma research lab

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Sodium Valproate Manufacturers in India Suppliers Sodium Valproate Exporters Distributors Sodium Valproate api active pharmaceuticals ingredients Sodium Valproate manufacturers Side Effects bulk drugs raw material Sodium Valproate companies Side Effects Importers Sodium Valproate Sodium Valproate Exporters Sodium Valproate exporters FDA Sodium Valproate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Sodium Valproate manufacturing pharmaceutical drugs pharmaceutical intermediates Sodium Valproate pharmaceutical chemicals pharmaceutical raw materials Sodium Valproate active pharmaceutical ingredients Sodium Valproate committee active pharmaceutical ingredients manufacturer Sodium Valproate Active Pharmaceutical Ingredients manufacturer Sodium Valproate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Sodium Valproate, Sodium Valproate manufacturer India, Sodium Valproate product, Sodium Valproate products, Api preparation, Certificate of Analysis API manufacturer product, Sodium Valproate anti ulcer product, Certificate of Origin COA Sodium Valproate COS Sodium Valproate, pharmaceutical generic, pharmaceutical drug, medical, Sodium Valproate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Sodium Valproate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Sodium Valproate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Sodium Valproate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Sodium Valproate ingredients, api, HIV Sodium Valproate, tablets, capsules, syrup & protein Sodium Valproate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Sodium Valproate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Sodium Valproate WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

sodium valporate tablets

HOME >> API >> API List 3 >> Sodium Valproate >> Interaction

Sodium Valproate CAS number 1069-66-5
DRUG DESCRIPTION | DOSAGE SIDE EFFECTS | PRECAUTIONS | INTERACTION | CONSUMER INFORMATION | PDF DOWNLOAD | WORD DOCUMENT | Details

INTERACTION
Sodium Valproate CAS number 1069-66-5

If you are taking enteric-coated sodium valproate tablets it is important that you don't take indigestion remedies (antacids) at the same time of day as the tablets. This is because indigestion remedies can make the special 'enteric coating' ineffective.

Sodium valproate may increase the blood levels of the following medicines. As this could increase the risk of their side effects, your doctor may need to reduce the dose of these medicines if you taken them in combination with sodium valproate:

* benzodiazepines such as lorazepam

* bupropion

* lamotrigine (sodium valproate may also increase the risk of skin reactions associated with lamotrigine)

* phenobarbital

* phenytoin (phenytoin blood levels should be monitored if taken with sodium valproate)

* primidone

* tricyclic antidepressants such as amitriptyline and nortriptyline

* zidovudine.

There may be increased drowsiness and sedation if sodium valproate is taken with benzodiazepines, eg diazepam.

There may be an increased risk of side effects on the liver if sodium valproate is taken with phenytoin or carbamazepine.

There may be an increased chance of side effects such as dizziness, tiredness, blurred vision and vomiting if sodium valproate is taken with carbamazepine.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.